Hydrafacial
approximately million cash and cash equivalents on balance sheet approximately million private warrants outstanding million convertible notes due use of proceeds capped call transaction potential future acquisitions working capital expenditures and general corporate purposes conversion price of capped call agreement provides dilution protection up to million senior secured credit facility remains undrawn current undrawn commitment fee of allows flexibility for future a us operations unencumbered convertible debt excluded from covenants approximately million current shares outstanding million accelerated share repurchase program expected to be completed by the end of additional million share authorization remaining highlights | Hydrafacial
Company
Deck Type
Deck date
November 2022
Slide
31 of 35
Similar slides by Hydrafacial
Results
August 2023
Results
May 2023
Results
February 2023
Results
August 2022
Related slides by other companies
Investor Presentation
May 2021
Investor Presentation
November 2022
Investor Presentation
March 2021
Results
July 2018
Other recent decks by Hydrafacial
Results
August 2023
Results
May 2023
Results
February 2023
Investor Presentation
November 2022
Search Thousands of Presentations by World Leading Companies